NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
Medically reviewed on by
Regional Medical Director Greater St. Louis
Psychedelics are a promising new category of drug treatment on the horizon. These drugs, which include psilocybin, mescaline, and LSD, are currently experimental and not approved by the FDA. But research shows that these substances – under medical supervision - can be a potential powerful treatment for major depression and other conditions.
Research on the possible therapeutic role of psychedelics actually took off in the late 1950s and early 1960s. Psychedelic research was advancing, and several notable people documented their personal experiments with psychedelics. Joel Elkes, a founding member of the American College of Neuropsychopharmacology (ACNP), openly experimented with LSD in the 1950s. And, famous author Aldous Huxley wrote an entire book, The Doors of Perception, about his use of the psychedelic, mescaline.
This research came to a screeching halt in the late 1960’s, with a growing awareness of the potential downsides of psychedelic use, and a strong political sentiment against psychedelics in the US. Finally, the Controlled Substances Act of 1970 shut down further research for decades. This research has picked up again only in recent years, and the results look promising. But still, for now these medications are not yet approved by the FDA, and are not available for therapeutic use outside of occasional clinical studies. Over the coming years, we’ll learn more about what psychedelics can and cannot do to help people with depression and other conditions.
Although psychedelics are not yet ready as an option, there is another new treatment for major depression that is available today. Esketamine nasal spray is already proven to be effective. It is FDA-approved, and covered by insurance.
Greenbrook TMS is a certified esketamine nasal spray provider. In a typical esketamine nasal spray treatment schedule, you’ll receive two treatments per week for four weeks, and then one treatment per week for the next four weeks. After that, treatment is typically once every one or two weeks.
You’ll receive your treatment in a relaxing area, in a comfy chair in your own private room or cubicle. Throughout your two-hour session, your care team will monitor you, and will be available if you need anything. In addition, the medical provider will be nearby, and will make rounds during your treatment to assess how you are doing.
Are you ready to take the next step in your journey to relieving symptoms of depression? To learn more about your options, schedule your free consultation with Greenbrook TMS or give us a call at 855-940-4867 today. We offer both esketamine, and TMS (transcranial magnetic stimulation).
Thanks for subscribing to our list!
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.